A service of StreetInsider.com
Welcome

Most Popular

AAPL 88.93
GOOG 265.99
RIMM 39.80
MSFT 18.61
C 6.45

Recently Added

KWR 10.56
FAS 17.50
CHC 0.56
FAZ 80.00
GNVC 0.43

Gaining Speed

MGG 13.01
OVEN 3.63
FAZ 80.00
GNVC 0.43
IFF 28.66
2.90 -0.07 (-2.37%) PARD

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:2.90 Change:-0.07 (-2.37%) Prev Close:2.97 Open: 2.95 Days Range:2.88 – 3.00 52 Week Range: 2.25 - 6.39 Volume:52623 P/E: N/A
EPS:-1.08

Member Comments

No member comments available for PARD


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 12/01/08

Recent Alert on 11/24/08 at 8:52am
Poniard Pharmaceuticals (PARD) Announces Commercial Supply Agreement for Picoplatin

Poniard Pharmaceuticals (Nasdaq: PARD) announced an agreement with Baxter Oncology GmbH for the commercial manufacture and supply of injectable picoplatin drug product. Poniard is developing picoplatin, its lead product candidate, as a potential new... Read More

Recent Alert on 11/24/08 at 8:52am
Poniard Pharmaceuticals (PARD) Announces Commercial Supply Agreement for Picoplatin
Recent Alert on 10/30/08 at 4:25pm
Poniard Pharmaceuticals (PARD) Reports Q3 Loss of 36c
Recent Alert on 10/22/08 at 10:17am
Poniard Pharmaceuticals (PARD) Reports Positive Efficacy and Safety Data from Phase 2 Trials on Picoplatin

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 11/10/08 at 5:48am
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
Blog Posts on 05/30/08 at 2:42am
Poniard Pharmaceuticals: Platinum Rediscovered (Part I)
Blog Posts on 05/24/08 at 4:44am
Poniard Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
Blog Posts on 10/03/07 at 11:20am
Analyst initiations: AMD, INTC, NTCT, GUID and NDAQ